Sera Prognostics (SERA) Non-Current Debt (2020)
Sera Prognostics (SERA) reported Non-Current Debt of $348000.0 for Q4 2020.
Sera Prognostics (SERA) Non-Current Debt (2020) Analysis & Trends
Sera Prognostics has reported Non-Current Debt for 1 years, with the latest figure at $348000.0 in Q4 2020.
- For the quarter ending Q4 2020, Non-Current Debt changed N/A year-over-year to $348000.0; the trailing twelve-month figure through Dec 2020 stood at $348000.0 (changed N/A YoY), and the FY2020 full-year result was $348000.0, changed N/A from the prior year.
- Non-Current Debt for Q4 2020 stood at $348000.0.
- The five-year high for Non-Current Debt was $348000.0 in Q4 2020, with the low at $348000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 27.88 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.81 Bn |
| 10 | Sera Prognostics | 93.48 Mn | 93.48 Mn | -28,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 348,000.00 |
| Dec 31, 2020 | 348,000.00 |